Skip to main content
. 2020 Mar;8(3):188–198. doi: 10.1016/j.jchf.2019.09.011

Figure 2.

Figure 2

Cumulative Incidence of Cardiovascular Death or Hospitalization for Heart Failure According to Baseline SBP Categories

Kaplan-Meier curves for cardiovascular death or hospitalization for heart failure, overall, and in each SBP category. The p value is for interaction between baseline SBP categories and treatment effect. The risk table below the graphs shows the number at risk of the event of interest. MRA denotes mineralocorticoid receptor antagonist. Abbreviations as in Figure 1.